Chemotherapy Research and Practice

Table of Contents: 2011

  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 965826
  • - Research Article

Development of an Oral Form of Azacytidine: Triacetyl-5-Azacytidine

Amy Ziemba | Eugene Hayes | ... | Giuseppe Pizzorno
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 878912
  • - Review Article

New Agents Targeting Angiogenesis in Glioblastoma

Eleni Timotheadou
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 218431
  • - Research Article

Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2000 and 2009: Epidemiology and Profiles of Resistance

Ziad Daoud | Claude Afif
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 602812
  • - Clinical Study

Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma

Seema Nagpal | Griffith Harsh | Lawrence Recht
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 730360
  • - Review Article

Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer

Toru Mukohara
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 839742
  • - Review Article

Neoadjuvant Treatment in Rectal Cancer: Actual Status

Ingrid Garajová | Stefania Di Girolamo | ... | Giovanni Brandi
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 843019
  • - Review Article

Neurotoxicity Caused by the Treatment with Platinum Analogues

Sousana Amptoulach | Nicolas Tsavaris
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 696208
  • - Review Article

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options

Ayca Gucalp | Tiffany A. Traina
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 163736
  • - Case Report

A Regimen of Taxol, Ifosfamide, and Platinum for Recurrent Advanced Squamous Cell Cancer of the Anal Canal

Diana V. Golub | A. Cahid Civelek | Vivek R. Sharma
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 270932
  • - Research Article

Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia

Wioletta Baranska-Rybak | Oscar Cirioni | ... | Wojciech Kamysz
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 806256
  • - Review Article

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia

Taymaa May | Donald P. Goldstein | Ross S. Berkowitz
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 619321
  • - Review Article

Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections

Kristina Nadrah | Franc Strle
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 393976
  • - Research Article

Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults

Pauline Byakika-Kibwika | Mohammed Lamorde | ... | Concepta Merry
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 989520
  • - Research Article

Susceptibility of Bifidobacteria of Animal Origin to Selected Antimicrobial Agents

Sigrid Mayrhofer | Christiane Mair | ... | Konrad J. Domig
  • Chemotherapy Research and Practice -
  • Special Issue
  • Volume 2011
  • - Article ID 218750
  • - Research Article

Antibacterial and Antioxidant Properties of the Methanolic Extract of the Stem Bark of Pteleopsis hylodendron (Combretaceae)

Aristide Laurel Mokale Kognou | Rosalie Annie Ngono Ngane | ... | Paul Henri Amvam Zollo

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.